Form Type: 4

SEC EDGAR Link
Accession Number:0001628280-22-000338
Date:2022-01-03
Issuer: ARENA PHARMACEUTICALS INC (ARNA)
Original Submission Date:

Reporting Person:

LISICKI ROBERT
C/O ARENA PHARMACEUTICALS, INC.
6154 NANCY RIDGE DRIVE SAN DIEGO, CA 92121

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-01-03 A 21,462 a $0.00 37,563 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the amount represents restricted stock units that vest over four years, with 25% of the shares underlying the restricted stock units vesting on february 15, 2023, and the remainder vesting quarterly over the following three years in equal installments (except as otherwise necessary to avoid vesting of a fractional share), with such quarterly vesting dates occurring on the 15th of may, august, november, and february. the shares underlying the restricted stock units will be issued upon vesting and release of the restricted stock units.

Elevate your investments